Assessment of Risk Factors of Hepatotoxicity among Tuberculosis Patients

Assessment of Risk Factors of Hepatotoxicity among Tuberculosis Patients

Tuberculosis is a devastating disease caused by Mycobacterium tuberculosis. If left untreated or not properly treated, it could lead to progressive tissue damage and even death. Short-term chemotherapy containing isoniazid, rifampicin. and pyrazinamide were proven to be very effective in the treatme...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Muhammad F. Wardhana, Tiana Milanda, Sri A. Sumiwi
Formatua:	Artikulua
Hizkuntza:	English
Argitaratua:	Universitas Padjadjaran 2018-04-01
Saila:	Pharmacology and Clinical Pharmacy Research
Sarrera elektronikoa:	http://jurnal.unpad.ac.id/pcpr/article/view/16450

Antzeko izenburuak

RISK ASSESSMENT AND MONITORING OF HEPATOTOXIC REACTIONS IN TUBERCULOSIS PATIENTS
nork: D. A. IVАNOVА, et al.
Argitaratua: (2017-10-01)

Sub-chronic toxicity of Garcinia atroviridis Griff Fruit's ethanol extract on Wistar rats (Ratus norvegicus)
nork: Tiana Milanda, et al.
Argitaratua: (2019-01-01)

Hepatotoxicity Effects of Alcohol Consumption during Paracetamol Therapy of Malaria Patients
nork: Funny Dinge, et al.
Argitaratua: (2017-08-01)

Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment
nork: Williams Ngouleun, et al.
Argitaratua: (2016-01-01)

The Effect of Anti-Tuberculosis Drugs on the Effectiveness of Anti-Retroviral Therapy in HIV-AIDS Patients
nork: Hasriana Hasriana, et al.
Argitaratua: (2017-04-01)

Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia
nork: Molla Y, et al.
Argitaratua: (2021-01-01)

Hepatotoxicity due to rifampicin, isoniazid and pyrazinamide in patients with tuberculosis: Is anti-HCV a risk factor?
nork: Lysandro Alsina Nader, et al.
Argitaratua: (2010-01-01)

Risk Factors of Antituberculosis Induced-Hepatotoxicity among HIV/AIDS Patients
nork: Lies Luthariana, et al.
Argitaratua: (2017-03-01)

Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis.
nork: Nino Lomtadze, et al.
Argitaratua: (2013-01-01)

Antituberculosis Drug-induced Hepatotoxicity in Pediatric Tuberculosis
nork: Vycke Yunivita, et al.
Argitaratua: (2019-10-01)

Frequency of Hepatotoxicity in Pulmonary Tuberculosis Patients taking Anti-Tuberculosis Therapy
nork: Farkhanda Noureen, et al.
Argitaratua: (2017-07-01)

Anti-tuberculosis therapy-induced hepatotoxicity among Ethiopian HIV-positive and negative patients.
nork: Getnet Yimer, et al.
Argitaratua: (2008-03-01)

Increased risk of hepatotoxicity and hyperuricemia in elderly Taiwanese multidrug-resistant tuberculosis patients taking pyrazinamide
nork: D. Truong, et al.
Argitaratua: (2016-08-01)

HEPATOTOXIC REACTIONS AND HEPATOPROTECTIVE THERAPY IN TUBERCULOSIS CONTROL
nork: G. S. Balasanyants
Argitaratua: (2015-08-01)

The effect of Polymorphism of the MDR1 (ABCB1) Gene on the Risk of Hepatotoxic Reactions in Patients with Pulmonary Tuberculosis
nork: М. А. Alymenko, et al.
Argitaratua: (2023-12-01)

Pharmacological correction of hepatotoxicity induced by anti-tuberculosis drugs
nork: D. S. Sukhanov, et al.
Argitaratua: (2023-04-01)

Effect of Genetic Polymorphism of the Enzyme Genes Responsible for Biotransformation of Antituberculous Drug on the Risk of Hepatotoxic Reaction in Patients with Tuberculosis
nork: A. V. Kazakov, et al.
Argitaratua: (2020-05-01)

Factors Enhancing Drug-induced Hepatotoxicity among Thai Patients with TB
nork: Santisith Khiewkhern, et al.
Argitaratua: (2020-09-01)

Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus
nork: Pingzheng Mo, et al.
Argitaratua: (2014-11-01)

Validity and reliability of “Short-questionnaire of tuberculosis patients’ knowledge about anti-tuberculosis and hepatotoxicity” (SQ-KSH-TB)
nork: Dyah Aryani Perwitasari, et al.
Argitaratua: (2023-03-01)

Uji Aktivitas Antibakteri dari Isolat Daun Tendani (Goniothalamus Macrophyllus Hook. f. & Thomson.)
nork: Viriyanata Wijaya, et al.
Argitaratua: (2016-12-01)

Risk Factors for Hepatotoxicity Due to Paracetamol Overdose in Adults
nork: Iwona Popiolek, et al.
Argitaratua: (2021-07-01)

Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity
nork: Mohammed A. Agha, et al.
Argitaratua: (2015-01-01)

NAT2 Gene rs1041983 is Associated with Anti-Tuberculosis Drug Induced Hepatotoxicity Among Pediatric Tuberculosis in Bandung, Indonesia
nork: Headriawan A, et al.
Argitaratua: (2021-06-01)

Influence of the Acetylation Type on the Incidence of Isoniazid-Induced Hepatotoxicity in Patients with Newly Diagnosed Pulmonary Tuberculosis
nork: N. M. Krasnova, et al.
Argitaratua: (2020-11-01)

Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS.
nork: Carolline Araújo-Mariz, et al.
Argitaratua: (2016-01-01)

The impact of the infection caused by hepatitis B and C on the characteristics of hepatotoxic reactions in tuberculosis patients
nork: V. V. Dantsev, et al.
Argitaratua: (2020-08-01)

Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study
nork: Workicho A, et al.
Argitaratua: (2017-03-01)

Hepatotoxic reactions during treatment of newly diagnosed patients with pulmonary multiple drug resistant tuberculosis
nork: R. Yu. Аbdullаev, et al.
Argitaratua: (2019-08-01)

Fibrous Roots of Cimicifuga Are at Risk of Hepatotoxicity
nork: Yang Yu, et al.
Argitaratua: (2022-01-01)

Isolation, Characterization, and Identification Candidate of Probiotic Bacteria Isolated from Wadi Papuyu (Anabas testudineus Bloch.) a Fermented Fish Product from Central Kalimantan, Indonesia
nork: Yulistia Budianti Soemarie, et al.
Argitaratua: (2022-01-01)

Fermented foods as probiotics: A review
nork: Yulistia Budianti Soemarie, et al.
Argitaratua: (2021-01-01)

Incidence, mortality, and risk factors of immunotherapy-associated hepatotoxicity: A nationwide hospitalization analysis
nork: Simcha Weissman, et al.
Argitaratua: (2021-03-01)

Hepatotoxicity Among Poisoned Patients: A Cross-sectional Study
nork: Arezou Mahdavinejad, et al.
Argitaratua: (2022-10-01)

Nanoparticle-Encapsulated Plant Polyphenols and Flavonoids as an Enhanced Delivery System for Anti-Acne Therapy
nork: Ririn Puspadewi, et al.
Argitaratua: (2025-02-01)

Mutation and Characterization of an Albino Mutant of Monascus sp. Isolated from the Cikapundung River, Bandung
nork: TIANA MILANDA, et al.
Argitaratua: (2010-03-01)

Cardiometabolic risk factors among patients with tuberculosis attending tuberculosis treatment centers in Nepal
nork: Indra Prasad Poudyal, et al.
Argitaratua: (2020-09-01)

Farmakogenomik Hepatotoksisitas Obat Anti Tuberkulosis [Hepatotoxicity Pharmacogenomic of Anti Tuberculosis Drugs]
nork: Andri Dwi Wahyudi, et al.
Argitaratua: (2015-09-01)

Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study
nork: Min Kyoung Kim, et al.
Argitaratua: (2018-10-01)

Machine Learning Approaches to Predict Hepatotoxicity Risk in Patients Receiving Nilotinib
nork: Jung-Sun Kim, et al.
Argitaratua: (2021-05-01)